The endogenous enhancement of calcitonin in a human being has the ability to act as an analgesic and to treat osteoporosis, for example. Exogenous administration of calcitonin has disadvantages given its expense and the possible triggering of a hypersensitivity reaction and other side effects. The present invention provides the benefits of enhanced calcitonin through electrical stimulation that increases endogenous calcitonin levels without the need for exogenous administration of calcitonin.

 
Web www.patentalert.com

< Apparatus with weeping tip and method of use

< Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies

> Compositions and methods for the therapy and diagnosis of lung cancer

> Small organic molecule regulators of cell proliferation

~ 00211